» Articles » PMID: 12243365

Higher Frequency of Apolipoprotein E2 Allele in Type 2 Diabetic Patients with Nephropathy in Taiwan

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2002 Sep 24
PMID 12243365
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes is one of the major causes of end stage renal failure in Taiwan. Previous studies have indicated that lipid abnormalities might contribute to the development and progression of diabetic nephropathy (DN). Apolipoprotein E (apo E) regulates the metabolism of lipoproteins. Three different apo E alleles (epsilon2, epsilon3 and epsilon4) produce apo E isoproteins, apo E2, apo E3 and apo E4. Thus, the apo E gene polymorphism may be associated with DN.

Methods: To investigate the distribution of apo E genotype in type 2 diabetic Taiwanese, we examined 314 patients with type 2 diabetes (100 without nephropathy and 214 with nephropathy) and 150 age-matched normal controls. The diagnosis of nephropathy was made when daily protein loss exceeded 500 mg. The apo E gene polymorphism was analyzed by polymerase chain reaction.

Results: Our study found that the frequency of apo E2 allele was significantly higher in the diabetics with nephropathy- non-dialysis group (7.7%) and diabetics with nephropathy- dialysis group (7.7%) than in normal controls (1.7%) (p < 0.001) and diabetics without nephropathy (2.0%) (p < 0.01). The E3 and E4 allele frequencies were not significantly different among groups.

Conclusion: These findings imply that apo E polymorphism is apparently related to the development of DN in type 2 diabetes in Taiwan.

Citing Articles

Association of Apolipoprotein E Gene Polymorphism with Type 2 Diabetic Nephropathy in the Southern Chinese Population.

Gan C, Zhang Y, Zhang X, Huang Q, Guo X Int J Gen Med. 2023; 16:5549-5558.

PMID: 38034901 PMC: 10683650. DOI: 10.2147/IJGM.S440103.


The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.

Li T, Shi Y, Yin J, Qin Q, Wei S, Nie S Int Urol Nephrol. 2014; 47(1):117-30.

PMID: 25262148 DOI: 10.1007/s11255-014-0843-6.


Apo E gene polymorphism affects development of type 2 diabetic nephropathy in Asian populations, especially in East Asians: an updated meta-analysis.

Lin Y, Pan J, Jiang M, Tan J, Zhong W, Gong T Med Sci Monit. 2014; 20:1596-603.

PMID: 25196797 PMC: 4166221. DOI: 10.12659/MSM.892111.


APOE polymorphism and diabetic nephropathy.

Araki S Clin Exp Nephrol. 2013; 18(2):230-3.

PMID: 24026386 DOI: 10.1007/s10157-013-0862-0.


Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.

Li Y, Tang K, Zhang Z, Zhang M, Zeng Z, He Z Mol Biol Rep. 2010; 38(5):3243-52.

PMID: 20177792 DOI: 10.1007/s11033-010-9999-z.